No Data
No Data
Why Ionis Pharmaceuticals (IONS) Is the Biotech Stock With Biggest Upside Potential
Bernstein Maintains Ionis Pharmaceuticals(IONS.US) With Hold Rating, Maintains Target Price $51
Ionis Pharmaceuticals (IONS) Gets a Hold From Bernstein
The Analyst Verdict: Ionis Pharmaceuticals In The Eyes Of 5 Experts
Ionis Pharmaceuticals Analyst Ratings
RBC Capital Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $70